Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.010
-0.020 (-0.50%)
At close: Jul 11, 2025, 4:00 PM
3.980
-0.030 (-0.75%)
After-hours: Jul 11, 2025, 7:54 PM EDT

Aquestive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
39832513549156180
Upgrade
Market Cap Growth
-25.19%140.67%176.07%-68.73%-13.14%-3.55%
Upgrade
Enterprise Value
36928415585169229
Upgrade
Last Close Price
4.013.562.020.903.895.35
Upgrade
PS Ratio
6.825.642.671.023.073.92
Upgrade
PB Ratio
--5.40-1.27-0.41-1.90-3.71
Upgrade
EV/Sales Ratio
6.804.933.061.793.324.99
Upgrade
Debt / Equity Ratio
-0.64-0.63-0.31-0.48-0.69-0.83
Upgrade
Asset Turnover
0.470.730.880.800.810.65
Upgrade
Inventory Turnover
2.302.793.323.954.614.87
Upgrade
Quick Ratio
4.324.181.770.811.831.84
Upgrade
Current Ratio
4.874.682.241.012.152.12
Upgrade
Return on Assets (ROA)
-22.21%-24.21%-16.49%-44.16%-34.71%-37.93%
Upgrade
Return on Capital (ROIC)
------116.06%
Upgrade
Earnings Yield
-13.62%-13.60%-5.83%-111.37%-45.15%-31.01%
Upgrade
FCF Yield
-12.31%-11.07%-5.47%-22.20%-21.69%-25.56%
Upgrade
Buyback Yield / Dilution
-40.22%-41.58%-25.69%-27.99%-13.15%-32.71%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q